NDM-1-Producing Acinetobacter baumannii from Algeria
- 1 April 2012
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (4), 2214-2215
- https://doi.org/10.1128/aac.05653-11
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Dissemination of an NDM-2-Producing Acinetobacter baumannii Clone in an Israeli Rehabilitation CenterAntimicrobial Agents and Chemotherapy, 2011
- Global Spread of Carbapenemase-producingEnterobacteriaceaeEmerging Infectious Diseases, 2011
- NDM-2 carbapenemase in Acinetobacter baumannii from EgyptJournal of Antimicrobial Chemotherapy, 2011
- Does broad-spectrum -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?Journal of Antimicrobial Chemotherapy, 2011
- Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from IndiaJournal of Antimicrobial Chemotherapy, 2010
- Diversity, Epidemiology, and Genetics of Class D β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007
- Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiologyClinical Microbiology & Infection, 2006
- VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.2006